Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Doula support to reduce partner violence during pregnancy and early postpartum

Official title: Novel Doula Intervention to Leverage Clinic-community Connections to Support Perinatal Intimate Partner Violence Survivors

Run by University of Pittsburgh · NCT07165860 · Data updated 2026-11-12

This project will test whether pairing pregnant people who have experienced intimate partner violence with IPV-trained doulas during pregnancy, birth, and the first months after delivery reduces partner violence and improves related health outcomes compared with an active control.

More Domestic Violence trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment250 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations3 sites (Pittsburgh, Pennsylvania and 2 other locations)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedNovember 1, 2028
Study endsMay 1, 2029
Registry record updatedApril 16, 2026
Trial IDNCT07165860 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 18 or older, up to 24 weeks 6 days gestation (baseline around 22 weeks), who identify as IPV survivors, speak English or Spanish, live within 50 miles of Pittsburgh, and can provide safe contact information or accept a study cell phone.

Probably not a fit

People who are incarcerated, unable to consent, cannot provide safe contact information or a study phone, are beyond the gestational eligibility window, or do not identify as IPV survivors are unlikely to benefit from enrolling in this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-arm randomized trial enrolling 250 perinatal people who identify as intimate partner violence (IPV) survivors at three Pittsburgh sites. Participants are randomized to receive full-spectrum support from an IPV-trained community doula from ~22 weeks gestation through six months postpartum, or to an active control of two structured intakes from a victim services agency. The primary outcome is change in IPV coercive behaviors from baseline to 12 months; secondary outcomes include cannabis and tobacco use, depressive and anxiety symptoms, and unmet basic needs, with assessments at enrollment, 3, 6, and 12 months. The study also examines mediators and moderators of effect and collects implementation outcomes to inform real-world delivery.

Why it matters

Potential benefit: If successful, the intervention could reduce intimate partner violence among perinatal survivors and improve mental health, substance use, and basic needs during pregnancy and the first year postpartum.

How similar studies have gone: While doulas have demonstrated benefits for birth outcomes and patient experience, using IPV-trained doulas specifically to reduce partner violence is a relatively novel approach with limited prior randomized trial evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Perinatal IPV survivors are eligible if they:

* 1\) feel comfortable completing the study in Spanish or English
* 2\) are age 18 or older
* 3\) are no more than 24 weeks 6 days gestation (note: participants enrolled earliest at 18 weeks, baseline at 22 weeks with a 3 week window)
* 4\) identify as an IPV survivor by answering affirmatively to a definition of experiencing IPV
* 5\) live within a 50 mile radius of Pittsburgh, Pennsylvania
* 6\) able to provide safe and complete contact information or take a study cell phone

Exclusion Criteria:

* Unable to consent
* Do not meet inclusion criteria
* Cannot provide safe contact information or take a study cell phone
* Incarcerated

Where it's running

  • The Midwife Center
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Family Medicine Department
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Magee Women's Hospital
    Pittsburgh, Pennsylvania, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Maya I Ragavan — University of Pittsburgh
  • Study coordinator: Maya Ragavan
  • Email: ragavanm@chp.edu
  • Phone: 4126926545

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.